Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Entecavir (Juno)
Entecavir monohydrate 0.532mg equivalent to entecavir 0.5mg
Film coated tablet
Generic Partners (NZ) Limited
EirGen Pharma Limited, Waterford, Ireland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Entecavir (Juno)
Entecavir monohydrate 1.065mg equivalent to entecavir 1mg
Film coated tablet
Generic Partners (NZ) Limited
EirGen Pharma Limited, Waterford, Ireland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Entecavir (Generic Partners)
Entecavir monohydrate 0.532mg equivalent to entecavir 0.5mg
Film coated tablet
Generic Partners (NZ) Limited
EirGen Pharma Limited, Waterford, Ireland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Entecavir (Generic Partners)
Entecavir monohydrate 1.065mg equivalent to entecavir 1mg
Film coated tablet
Generic Partners (NZ) Limited
EirGen Pharma Limited, Waterford, Ireland
|
Dated this 19th day of April 2018.
ALISON COSSAR, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz